Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Small

Showing results (851-860 of 1,203) with videos related to

Pageof 121
Sort By:
American Journal of Physiology. Endocrinology and Metabolism|May 13, 2004
Regulation of rat pituitary cocaine- and amphetamine-regulated transcript (CART) by CRH and glucocorticoidsS A Stanley, K G Murphy, G A Bewick, et al.
Chemical Research in Toxicology|May 1, 1993
Identification and quantitation of benzo[a]pyrene-DNA adducts formed in mouse skinE G Rogan, P D Devanesan, N V RamaKrishna, et al.
Clinical Genitourinary Cancer|October 1, 2008
A phase II study of estramustine, docetaxel, and exisulind in patients with hormone- refractory prostate cancer: results of cancer and leukemia group B trial 90004Nancy A Dawson, Susan Halabi, San-San Ou, et al.
Cancer|July 23, 2008
Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancerCelestia S Higano, John M Corman, David C Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisoneE J Small, M Meyer, M E Marshall, et al.
Bone Marrow Transplantation|December 23, 2017
Sleep disruption among cancer patients following autologous hematopoietic cell transplantationAshley M Nelson, Heather S L Jim, Brent J Small, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 5, 2016
Characteristics and predictors of fatigue among men receiving androgen deprivation therapy for prostate cancer: a controlled comparisonAshley M Nelson, Brian D Gonzalez, Heather S L Jim, et al.
Ebiomedicine|February 13, 2016
A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance)Hyung L Kim, Susan Halabi, Ping Li, et al.
Harmful Algae|November 20, 2024
Investigating the role of allelochemicals in the interaction between Alexandrium monilatum and other phytoplankton speciesSylvain Gaillard, Hamish J Small, Nour Ayache, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2002
Biochemical disease-free survival following adjuvant and salvage irradiation after radical prostatectomyJohn A Kalapurakal, Cheng-Fang Huang, Manoj M Neriamparampil, et al.
Pageof 121

Showing results (851-860 of 1,203) with videos related to

Sort By:
Pageof 121
American Journal of Physiology. Endocrinology and Metabolism|May 13, 2004
Regulation of rat pituitary cocaine- and amphetamine-regulated transcript (CART) by CRH and glucocorticoidsS A Stanley, K G Murphy, G A Bewick, et al.
Chemical Research in Toxicology|May 1, 1993
Identification and quantitation of benzo[a]pyrene-DNA adducts formed in mouse skinE G Rogan, P D Devanesan, N V RamaKrishna, et al.
Clinical Genitourinary Cancer|October 1, 2008
A phase II study of estramustine, docetaxel, and exisulind in patients with hormone- refractory prostate cancer: results of cancer and leukemia group B trial 90004Nancy A Dawson, Susan Halabi, San-San Ou, et al.
Cancer|July 23, 2008
Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancerCelestia S Higano, John M Corman, David C Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisoneE J Small, M Meyer, M E Marshall, et al.
Bone Marrow Transplantation|December 23, 2017
Sleep disruption among cancer patients following autologous hematopoietic cell transplantationAshley M Nelson, Heather S L Jim, Brent J Small, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 5, 2016
Characteristics and predictors of fatigue among men receiving androgen deprivation therapy for prostate cancer: a controlled comparisonAshley M Nelson, Brian D Gonzalez, Heather S L Jim, et al.
Ebiomedicine|February 13, 2016
A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance)Hyung L Kim, Susan Halabi, Ping Li, et al.
Harmful Algae|November 20, 2024
Investigating the role of allelochemicals in the interaction between Alexandrium monilatum and other phytoplankton speciesSylvain Gaillard, Hamish J Small, Nour Ayache, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2002
Biochemical disease-free survival following adjuvant and salvage irradiation after radical prostatectomyJohn A Kalapurakal, Cheng-Fang Huang, Manoj M Neriamparampil, et al.
Pageof 121